MCM
Moore Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-40,000
| Closed | -$5.51M | – | 468 |
|
|
2024
Q2 | $5.51M | Buy |
+40,000
| New | +$5.51M | 0.1% | 170 |
|
|
2023
Q4 | – | Sell |
-55,000
| Closed | -$6.19M | – | 456 |
|
|
2023
Q3 | $6.19M | Buy |
+55,000
| New | +$6.19M | 0.12% | 105 |
|
|
2021
Q1 | – | Sell |
-96,075
| Closed | -$9.21M | – | 729 |
|
|
2020
Q4 | $9.21M | Buy |
+96,075
| New | +$9.21M | 0.1% | 135 |
|
|
2019
Q2 | – | Sell |
-54,213
| Closed | -$4.78M | – | 333 |
|
|
2019
Q1 | $4.78M | Buy |
54,213
+10,422
| +24% | +$918K | 0.15% | 142 |
|
|
2018
Q4 | $3.13M | Buy |
+43,791
| New | +$3.13M | 0.12% | 110 |
|
|
2016
Q1 | – | Sell |
-130,000
| Closed | -$7.35M | – | 291 |
|
|
2015
Q4 | $7.35M | Buy |
130,000
+95,000
| +271% | +$5.37M | 0.23% | 111 |
|
|
2015
Q3 | $1.39M | Sell |
35,000
-20,000
| -36% | -$796K | 0.07% | 194 |
|
|
2015
Q2 | $2.63M | Buy |
+55,000
| New | +$2.63M | 0.06% | 232 |
|